神経学および神経科学ジャーナル

  • ISSN: 2171-6625
  • ジャーナル h-index: 17
  • 雑誌引用スコア: 4.43
  • ジャーナルのインパクトファクター: 3.38
インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • グローバル インパクト ファクター (GIF)
  • 中国国家知識基盤 (CNKI)
  • 研究ジャーナル索引作成ディレクトリ (DRJI)
  • OCLC-WorldCat
  • プロクエスト召喚
  • 科学雑誌インパクトファクター (SJIF)
  • ユーロパブ
  • Google スカラー
  • 秘密検索エンジン研究所
このページをシェアする

抽象的な

Utilizing Digital Therapeutics (JOGO) to treat Neuromuscular Dyssynergic Defecation

Uma Venkatesa

Digital therapeutics (DTx) , also known as Software as a Medical Device (SaMD) is a newly defined term by the International Medical Device Regulators Forum (IMDRF) for software to be used as a treatment. JOGO is a  DTx that is built based on the science of Electromyography Biofeedback (EMG BF) to facilitate neuromuscular retraining. Combining software and wearable EMG sensors with conventional therapy (CT), JOGO improved the quality of life for a 32 year old patient with slow transit, constipation with type 4 defecation dyssynergia. JOGO’s ease of use through features such as mobile gamification increases patient compliance relative to CT, augmenting clinical outcome. The patient received eight JOGO integrated therapy sessions over the course of three months. Protocol included relaxation exercises (mind and body, including yoga), a high fiber diet, and pelvic floor stretching/relaxation/bulge out exercises, external pelvic muscle stretching (gluteus maximus, hamstrings etc.) and biofeedback therapy. After the sessions, the patient was able to control bowel movements without straining. Initial muscle potential for relaxation was 19 mVs and for contraction was 67 mVs. Post therapy, the patient's muscle potential for relaxation was 9 mVs and for contraction 70 mVs. JOGO integrated therapy helped acquire the goal of improving the patient’s incoordination of pelvic and abdominal muscles. Further studies are in the process to investigate improving this treatment.